Hanyang Med Rev.  2009 Nov;29(4):298-305. 10.7599/hmr.2009.29.4.298.

Obstetric Management of the Low Birth Weight Related to Preterm Birth and Intrauterine Growth Retardation

• Roh J

• KMID: 2053716
• DOI: http://doi.org/10.7599/hmr.2009.29.4.298

Abstract

The small baby is a major challenge of modern obstetrics. Not only is low birth weight the most important factor associated with perinatal mortality but there are also dangers of short and long term mental or physical handicap in survivors. General management includes treatment of maternal disease, cessation of substance abuse, good nutrition and institution of bed rest. Although not of proven benefit, bed rest may maximize uterine blood flow. In any case, antenatal testing should be instituted. Because the task of the obstetrician is to deliver the baby in the best possible condition, which is possible only if the baby at risk has been recognized during the antenatal period, the place of intrapartum monitoring and the use of cesarean section in the management of the small baby are questions of everyday relevance to the practicing obstetrician. Delivery should be in a hospital capable of dealing with the various neonatal morbidities associated with growth restriction, including asphyxia, sepsis and malformations. Minimizing hypoxic episodes during labor and delivery, as well as optimizing neonatal care for these infants, will likely produce the healthiest outcome.

Keyword

Low-birth weight; Preterm birth; Intrauterine growth retardation; Obstetrics

MeSH Terms

Asphyxia
Bed Rest
Cesarean Section
Female
Fetal Growth Retardation
Humans
Hypogonadism
Infant
Infant, Low Birth Weight
Infant, Newborn
Mitochondrial Diseases
Obstetrics
Ophthalmoplegia
Perinatal Mortality
Pregnancy
Premature Birth
Sepsis
Substance-Related Disorders
Survivors
Hypogonadism
Mitochondrial Diseases
Ophthalmoplegia

Reference

1. Finer NN, Horbar JD, Carpenter JH. Cardiopulmonary resuscitation in the very low birth weight infant: the Vermont Oxford Network experience. Pediatrics. 1999; 104:428–434.

2. Kiely JL. What is the population-based risk of preterm birth among twins and other multiples? Clin Obstet Gynecol. 1998; 41:3–11.

3. Susan AF, David AC. Prematurity: Follow-up. Contemporary OB-GYN. 2002; 65–90.

4. Edge V, Laros RK Jr. Pregnancy outcome in nulliparous women aged 35 or older. Am J Obstet Gynecol. 1993; 168:1881–1885.

5. Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R. The perinatal effects of delayed childbearing. Obstet Gynecol. 2005; 105:1410–1418.

6. Morken NH, Kallen K, Hagberg H, Jacobsson B. Preterm birth in Sweden 1973-2001: Rate, subgroup, and effect of changing patterns in multiple births, maternal age, and smoking. Acta Obstet Gynecol Scand. 2005; 84:558–565.

7. Kyrklund-Blomberg NB, Granath F, Cnattingius S. Maternal smoking and cause of very preterm birth. Acta Obstet Gynecol Scand. 2005; 84:572–577.

8. Keogh J, Sinn J, Hollebone K, Bajuk B, Fischer W, Lui K. Consensus Workshop Organising Committee. Delivery in the 'grey zone': Collaborative approach to extremely preterm birth. Aust N Z J Obstet Gynaecol. 2007; 47:273–278.

9. Kim MK, Won HS, Shin MS, Kim SR, Chung JY, Lee PR, Lee IS, Kim A. The Clinical Utility of Amnioinfusion in Oligohydroamnios following PPROM. Korean J Obstet Gynecol. 2001; 44:364–368.

10. Park YH, Choi SK, Choi YK, Lee JH, Moon HB, Kim SJ, Oh MJ, Shin JC, Kim SP. Amnioinfusion in preterm premature rupture of membranes. Korean J Obstet Gynecol. 2001; 44:2078–2083.

11. ACOG Committee on Practice Bulletins. American College of Obstetricians and Gynecologist. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol. 2003; 101:1039–1047.

12. Helmer H. Frequently asked questions on tocolytics. BJOG. 2005; 112:Suppl 1. 94–96.

13. Rodts-Palenik S, Morrison JC. Tocolysis: an update for the practitioner. Obstet Gynecol Surv. 2002; 57:S9–s34.

14. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol. 2001; 97:840–847.

15. King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol. 2003; 43:192–198.

16. Thornton JG. Maintenance tocolysis. BJOG. 2005; 112:Suppl 1. 118–121.

17. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol. 2002; 186:843–849.

18. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000; 342:1500–1507.

19. Tejani NA. Recurrence of intrauterine growth retardation. Obstet Gynecol. 1982; 59:329–331.

20. Hadlock FP, Deter RL, Harrist RB, Roecker E, Park SK. A date-independent predictor of intrauterine growth retardation: femur length/abdominal circumference ratio. AJR Am J Roentgenol. 1983; 141:979–984.

21. Rutherford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 1987; 70(3 Pt 1):353–356.

22. Golan A, Lin G, Evron S, Arieli S, Niv D, David MP. Oligohydramnios: maternal complications and fetal outcome in 145 cases. Gynecol Obstet Invest. 1994; 37:91–95.

23. Leitich H, Egarter C, Husslein P, Kaider AK, Schemper M. A meta-analysis of low dose aspirin for the prevention of intra uterine growth retardation. Br J Obstet Gynaecol. 1997; 104:450–459.

24. McCurdy CM Jr, Seeds JW. Oligohydramnios: problems and treatment. Semin Perinatol. 1993; 17:183–196.